ALKERMES | Aktywa



Current Assets Zmiana Data
AbbVie USD 25.58B 2.2B 2024-12
Acadia Pharmaceuticals USD 938.32M 150.03M 2024-12
ALKERMES USD 1.42B 167.74M 2024-12
Amgen USD 29.03B 2.26B 2024-12
Biogen USD 7.46B 626.3M 2024-12
BioMarin Pharmaceutical USD 3.23B 175.84M 2024-12
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Eli Lilly USD 41.26B 8.52B 2025-03
Gilead Sciences USD 19.17B 4.39B 2024-12
Ionis Pharmaceuticals USD 2.42B 201.36M 2025-03
J&J USD 71.55B 15.66B 2025-03
Malin Corporation EUR 35.9M 100K 2024-06
Merck USD 38.78B 1.58B 2024-12
Neurocrine Biosciences USD 1.72B 151.9M 2024-12
Otsuka Holdings JPY 1.32T 48.42B 2025-03
Pfizer USD 50.36B 7.14B 2024-12
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12



ALKERMES Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.